Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Res Neurobiol ; 4: 100068, 2023.
Article in English | MEDLINE | ID: mdl-36589675

ABSTRACT

Insulin-like growth factor-1 (IGF-1) plays critical roles in the development of the central nervous system (CNS), including the retina, regulating cell proliferation, differentiation, and survival. Here, we investigated the role of IGF-1 on retinal cell proliferation using primary cultures from rat neural retina. Our data show that IGF-1 stimulates retinal cell proliferation and regulates the expression of neurotrophic factors, such as interleukin-4 and brain-derived neurotrophic factor. In addition, our results indicates that IGF-1-induced retinal cell proliferation requires activation of multiple signaling pathways, including phosphatidylinositol 3-kinase, protein kinase Src, phospholipase-C, protein kinase C delta, and mitogen-activated protein kinase pathways. We further show that activation of matrix metalloproteinases and epidermal growth factor receptor is also necessary for IGF-1 enhancing retinal cell proliferation. Overall, these results unveil potential mechanisms by which IGF-1 ensures retinal cell proliferation and support the notion that manipulation of IGF-1 signaling may be beneficial in CNS disorders associated with abnormal cell proliferation.

2.
Neurochem Res ; 34(5): 884-90, 2009 May.
Article in English | MEDLINE | ID: mdl-18802750

ABSTRACT

Protein kinase C (PKC) plays a key role in cellular events including proliferation, survival and differentiation. Our previous study showed the effect of phorbol 12-myristate 13-acetate (PMA), a PKC activator, inducing a decrease in retinal cells proliferation. This effect was mediated by muscarinic type 1 receptors (M1) activation and brain derived neurotrophic factor (BDNF) treatment also induced a decrease in cell proliferation. Based on these results we analyzed the expression of either M1 receptors or BDNF following PMA treatment of retinal cell cultures. Our data demonstrated that PMA induced a decrease in both protein expressions after 48 h in culture. However, after 45 min, PMA induced a transient increase in BDNF expression and a decrease in M1 receptors expression. Analyzing the expression of M1 receptors and BDNF during the postnatal development in vivo, we observed a decrease in both proteins. Taken together our results suggest the involvement of PKC in the control of M1 expression in retinal cells.


Subject(s)
Brain-Derived Neurotrophic Factor/biosynthesis , Protein Kinase C/physiology , Receptor, Muscarinic M1/biosynthesis , Retina/metabolism , Animals , Cell Proliferation/drug effects , Cells, Cultured , Enzyme Activation , Gene Expression Regulation , Rats , Retina/cytology , Retina/growth & development , Tetradecanoylphorbol Acetate/pharmacology
3.
Neurochem Int ; 42(1): 73-80, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12441170

ABSTRACT

Protein kinase C (PKC) is involved in several cell events including proliferation, survival and differentiation. The aim of this work was to investigate the role of PKC activation on retinal cells proliferation. We demonstrated that PKC activation by phorbol 12-myristate 13-acetate (PMA), a tumor promoter phorbol ester, is able to decrease retinal cells proliferation. This effect was mediated by M1 receptors and dependent on intracellular Ca(2+) increase, tyrosine kinase activity, phosphatidylinositol 3-kinase activity, polypeptide secretion and activation of TrkB receptors. The effect of PMA was not via activation of mitogen-activated protein (MAP) kinase. Carbamylcholine and brain derived neurotrophic factor were both able to decrease retinal cells proliferation to the same level as PMA did. Our results suggest that PKC activation leads to a decrease in retinal cells proliferation through the release of acetylcholine and brain derived neurotrophic factor in the culture, and activation of M1 and TrkB receptors, respectively.


Subject(s)
Acetylcholine/physiology , Brain-Derived Neurotrophic Factor/pharmacology , Carbachol/pharmacology , Eye Proteins/metabolism , Growth Inhibitors/pharmacology , Pirenzepine/analogs & derivatives , Protein Kinase C/metabolism , Receptors, Muscarinic/drug effects , Retina/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Alkaloids , Amacrine Cells/drug effects , Animals , Atropine/pharmacology , Benzophenanthridines , Calcium/pharmacology , Cell Division/drug effects , Cells, Cultured/drug effects , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Eye Proteins/drug effects , Isoenzymes/drug effects , Isoenzymes/metabolism , MAP Kinase Signaling System/drug effects , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Oxotremorine/pharmacology , Phenanthridines/pharmacology , Pirenzepine/pharmacology , Protein Kinase C/drug effects , Rats , Receptor, Muscarinic M1 , Receptors, Muscarinic/physiology , Retina/cytology , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...